updates in newly diagnosed and r/r aml
Published 2 years ago • 145 plays • Length 3:55Download video MP4
Download video MP3
Similar videos
-
3:29
opb-11077 for newly diagnosed and r/r aml: phase ib update
-
2:31
updates in the diagnosis, risk stratification & treatment of aml: who, icc, and eln classifications
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
0:55
the role of rna modifications in mds and aml
-
2:58
feasibility and safety of early discharge in nd aml following intensive induction therapy
-
4:33
maintenance and continuous treatment in acute myeloid leukemia
-
1:14:27
major treatment decisions for patients with acute myeloid leukemia (aml)
-
7:46
updates in aml treatment and research from asco 2023
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
1:26
braf-mutated aml is associated with poor prognosis and myelodysplasia-related mutations
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl
-
2:45
continuity of care for patients with hematological predispositions to aml
-
0:37
the mechanism of treatment resistance in aml: do cd8-expressing t-cells become exhausted?
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
1:52
impact of recent advancements in treatment of r/r aml on os in clinical practice
-
1:02
the impact of sequencing in aml
-
2:03
maintenance therapy in aml
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
1:11
the treatment of aml within the united kingdom nhs framework
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
2:41
advancements in aml: an update from ash 2023